Has Fred Murphy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,661 in general payments to Fred Murphy, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fred Murphy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fred Murphy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fred Murphy, MD

Internal Medicine · Magnolia, ARNPI 1629181433

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,738 of the $6,661 with a category attached, or 86.1%. Novartis accounts for 99.5% of it on its own, with 1 other manufacturer making up the rest. Among internal medicine clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,661in general payments, 2019–2025

Across 9 payments — averaging $740.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$7K
Johnson & Johnson$35

What the payments were for

Consulting fees$5,73886%
Travel & lodging$5658%
Food & beverage$3585%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	7	$6,625
Johnson & Johnson	2	$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COSENTYX$6,542

How this compares

$6,661 in reported general payments places this provider in the 90th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas →

Medicare billing

Part B allowed, 2024

$518,327

Medicare patients

332

Services billed

4,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	12	$4,623
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide	11	$26
Metoprolol Tartrate	12	$19

Paid to pharmacies, not to this prescriber.

Other internal medicine in Magnolia

Jason FranksMagnolia$7K
David PyleJonesboro$93K
Aaron StrobelLittle Rock$32K
Stuart BensonRogers$24K
Purnima SarkarEarle$21K
John NorwoodJonesboro$21K
Ahmed AliConway$18K
Jeremy DavisLittle Rock$17K
Tyree SealsFort Smith$14K
Atif KhanBatesville$14K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →